FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3025509561> ?p ?o ?g. }

• W3025509561 endingPage "644" @default.
• W3025509561 startingPage "631" @default.
• W3025509561 abstract "Tumor cells alter the expression of RBP splicing factors to promote splicing associated with a tumorigenic state. The splicing machinery is frequently mutated in cancers and exerts differential effects on splicing but converges on downstream signaling pathways. Neoepitopes can arise from aberrant splicing in cancer cells and signify a new avenue as immunotherapeutic targets. A repertoire of therapeutic approaches has been developed to target splicing alterations across several cancers. RNA splicing is an essential process that governs many aspects of cellular proliferation, survival, and differentiation. Considering the importance of RNA splicing in gene regulation, alterations in this pathway have been implicated in many human cancers. Large-scale genomic studies have uncovered a spectrum of splicing machinery mutations that contribute to tumorigenesis. Moreover, cancer cells are capable of hijacking the expression of RNA-binding proteins (RBPs), leading to dysfunctional gene splicing and tumor-specific dependencies. Advances in next-generation RNA sequencing have revealed tumor-specific isoforms associated with these alterations, including the presence of neoantigens, which serve as potential immunotherapeutic targets. In this review, we discuss the various mechanisms by which cancer cells exploit RNA splicing to promote tumor growth and the current therapeutic landscape for splicing-based therapies. RNA splicing is an essential process that governs many aspects of cellular proliferation, survival, and differentiation. Considering the importance of RNA splicing in gene regulation, alterations in this pathway have been implicated in many human cancers. Large-scale genomic studies have uncovered a spectrum of splicing machinery mutations that contribute to tumorigenesis. Moreover, cancer cells are capable of hijacking the expression of RNA-binding proteins (RBPs), leading to dysfunctional gene splicing and tumor-specific dependencies. Advances in next-generation RNA sequencing have revealed tumor-specific isoforms associated with these alterations, including the presence of neoantigens, which serve as potential immunotherapeutic targets. In this review, we discuss the various mechanisms by which cancer cells exploit RNA splicing to promote tumor growth and the current therapeutic landscape for splicing-based therapies. located at the 3′ end of the intron and essential for correct RNA splicing. gene isoforms that arise specifically in tumorigenic states compared with normal tissues. receptor proteins that have been engineered into T cells to target a specific protein. age-related expansion of blood cells that arise from clonal hematopoietic cells. sequences that are typically not recognized by the spliceosome, however, mutations at canonical splice sites can lead to the activation of cryptic splice sites being used. monoclonal antibodies that target immune checkpoints. a type of alternative splicing in which an intron that is retained contains stop codons or a shift in the reading frame, consequently leading to mRNA degradation. differential usage of gene isoforms in response to a signal. surveillance pathway for degrading mRNA transcripts that contain premature stop codons. an exon that contains premature stop codons during alternative splicing and triggers the transcript to undergo nonsense mediated decay. a nucleic acid structure that is composed of a DNA: RNA hybrid and a nontemplate single-stranded DNA. Dissolution of R-loops is mediated by RNase H and unwarranted formation of R-loops induces genomic instability. substitution of a single nucleotide at a specific DNA sequence that can be found on protein-coding genes, noncoding sequences, and intergenic regions. co-occurrence of two or more genetic interactions that lead to cellular death. rare group of introns that do not contain the typical consensus sequences (splice site and branch point) and therefore utilize a minor spliceosome complex for RNA splicing." @default.
• W3025509561 created "2020-05-21" @default.
• W3025509561 creator A5031538988 @default.
• W3025509561 creator A5084923564 @default.
• W3025509561 date "2020-08-01" @default.
• W3025509561 modified "2023-10-16" @default.
• W3025509561 title "RNA Splicing and Cancer" @default.
• W3025509561 cites W1263857580 @default.
• W3025509561 cites W1506037097 @default.
• W3025509561 cites W1520966126 @default.
• W3025509561 cites W1533447420 @default.
• W3025509561 cites W1536775300 @default.
• W3025509561 cites W1829675031 @default.
• W3025509561 cites W1846422913 @default.
• W3025509561 cites W1915661113 @default.
• W3025509561 cites W1966532070 @default.
• W3025509561 cites W1968811042 @default.
• W3025509561 cites W1970108031 @default.
• W3025509561 cites W1977301794 @default.
• W3025509561 cites W1979233636 @default.
• W3025509561 cites W1986077139 @default.
• W3025509561 cites W1990393476 @default.
• W3025509561 cites W1993236149 @default.
• W3025509561 cites W1999609473 @default.
• W3025509561 cites W2006217199 @default.
• W3025509561 cites W2011458181 @default.
• W3025509561 cites W2011920499 @default.
• W3025509561 cites W2029979788 @default.
• W3025509561 cites W2036969473 @default.
• W3025509561 cites W2042386784 @default.
• W3025509561 cites W2043058822 @default.
• W3025509561 cites W2048255587 @default.
• W3025509561 cites W2058428463 @default.
• W3025509561 cites W2067826589 @default.
• W3025509561 cites W2073889874 @default.
• W3025509561 cites W2077813812 @default.
• W3025509561 cites W2082646723 @default.
• W3025509561 cites W2089822384 @default.
• W3025509561 cites W2091242855 @default.
• W3025509561 cites W2094488327 @default.
• W3025509561 cites W2097995306 @default.
• W3025509561 cites W2098835477 @default.
• W3025509561 cites W2110538588 @default.
• W3025509561 cites W2114706544 @default.
• W3025509561 cites W2129129812 @default.
• W3025509561 cites W2129766349 @default.
• W3025509561 cites W2130739371 @default.
• W3025509561 cites W2131769243 @default.
• W3025509561 cites W2138431129 @default.
• W3025509561 cites W2143350291 @default.
• W3025509561 cites W2145842706 @default.
• W3025509561 cites W2155570392 @default.
• W3025509561 cites W2155602880 @default.
• W3025509561 cites W2155804510 @default.
• W3025509561 cites W2157360354 @default.
• W3025509561 cites W2160078712 @default.
• W3025509561 cites W2166662937 @default.
• W3025509561 cites W2179454156 @default.
• W3025509561 cites W2193225046 @default.
• W3025509561 cites W2268478667 @default.
• W3025509561 cites W2295998134 @default.
• W3025509561 cites W2338046461 @default.
• W3025509561 cites W2375577403 @default.
• W3025509561 cites W2413340136 @default.
• W3025509561 cites W2418418689 @default.
• W3025509561 cites W2511911618 @default.
• W3025509561 cites W2513330489 @default.
• W3025509561 cites W2515397526 @default.
• W3025509561 cites W2516282811 @default.
• W3025509561 cites W2520178460 @default.
• W3025509561 cites W2546500680 @default.
• W3025509561 cites W2552513321 @default.
• W3025509561 cites W2569441881 @default.
• W3025509561 cites W2578166854 @default.
• W3025509561 cites W2590878552 @default.
• W3025509561 cites W2596064219 @default.
• W3025509561 cites W2605738899 @default.
• W3025509561 cites W2607978828 @default.
• W3025509561 cites W2734870195 @default.
• W3025509561 cites W2735636412 @default.
• W3025509561 cites W2747568591 @default.
• W3025509561 cites W2758475630 @default.
• W3025509561 cites W2765483614 @default.
• W3025509561 cites W2786842416 @default.
• W3025509561 cites W2788733333 @default.
• W3025509561 cites W2795871670 @default.
• W3025509561 cites W2795877840 @default.
• W3025509561 cites W2796827074 @default.
• W3025509561 cites W2808930783 @default.
• W3025509561 cites W2884219988 @default.
• W3025509561 cites W2885227878 @default.
• W3025509561 cites W2885934659 @default.
• W3025509561 cites W2887459058 @default.
• W3025509561 cites W2889035856 @default.
• W3025509561 cites W2896480326 @default.
• W3025509561 cites W2896719374 @default.
• W3025509561 cites W2897292730 @default.
• W3025509561 cites W2908027391 @default.

• next